ReviewJournal of clinical medicine2024

Efficacy and Safety of Rho Kinase Inhibitors vs. Beta-Blockers in Primary Open-Angle Glaucoma: A Systematic Review with Meta-Analysis.

Brenda Nana Wandji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.